Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos One|April 9, 2024
Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F proteinJudith Alamares-Sapuay, Michael Kishko, Charles Lai, et al.Communications Medicine|May 26, 2023
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamstersCatherine Berry, Vincent Pavot, Natalie G Anosova, et al.NPJ Vaccines|June 30, 2022
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticleJennifer N Rainho-Tomko, Vincent Pavot, Michael Kishko, et al.Science Immunology|May 3, 2020
A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domainKurt A Swanson, Jennifer N Rainho-Tomko, Zachary P Williams, et al.Vaccine|February 1, 2022
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity modelKirill V Kalnin, Timothy Plitnik, Michael Kishko, et al.NPJ Vaccines|April 20, 2021
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal modelsKirill V Kalnin, Timothy Plitnik, Michael Kishko, et al.Pageof 2